Cardionerds: A Cardiology Podcast cover image

194. Lipids: Omega-3 Fatty Acids & The Battle Of The Oils with Dr. Pam Taub

Cardionerds: A Cardiology Podcast

00:00

Is There a Barrier to Generic Ip?

The fta recently approved generic i pe. Is this going to help widen the cost burden of these medications? And are there any clinically significant differences that are worth noting between generic, brandname ip so this is a really interesting issue because there's a company, it's called hickma, and they had a big patent battle with amerin,. Now they have a generic ip e market that's been fda approved.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app